EDMONTON, Alberta, November 27, 2015 – BioNeutra Global Corporation (CSE: BGA) (“BioNeutra” or the “Company“) wishes to announce that the board of directors has approved a grant of stock options, exercisable to purchase an aggregate of 3,000,000 common shares of the Corporation, to directors, officers, employees and consultants of the Corporation. The options are exercisable at a price of $0.40 per common share for a three-year term.
All options are subject to any earlier termination in accordance with their terms. Additional details regarding this grant of stock options can be found in the Form 11 filed in accordance with the rules of the Canadian Securities Exchange, a copy of which is accessible at www.cnsx.ca under the Corporation’s profile.
Comments